Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure

Fig. 2

Correlation among BI status, ACLF grade, and short-term mortality was analysed in 290 patients with HBV-ACLF in the derivation cohort. a Comparison of admission BI incidence among three patient subgroups (ACLF-1, n = 70; ACLF-2, n = 139; ACLF-3, n = 81); b The 28-day mortality incidence was compared between patients with (n = 123) or without admission BI (n = 167), and was further compared within the ACLF-1 (with BI, n = 8; without BI, n = 62), ACLF-2 (with BI, n = 29; without BI, n = 71), and ACLF-3 (with BI, n = 86; without BI, n = 34) subgroups. c The 90-day mortality incidence was compared likewise. Categorical data are expressed as percentages (frequencies) and analysed using the Chi‐square test followed by Fisher’s exact test, as appropriate. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. ACLF was graded per the AARC ACLF score (5–7; 8–10; 11–15). Abbreviations: BI, bacterial infection; ACLF, acute-on-chronic liver failure; HBV-ACLF, hepatitis b related ACLF; AARC, Asian Pacific Society for the Study of the Liver ACLF research consortium

Back to article page